MarketInOut Stock Screener Log In | Sign Up

Conexeu Sciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Conexeu Sciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization88.8 mln
Float11.24 mln

Relative Strength

9 / 100
Severely lagging

Debt / Equity

0.01
Debt-free

ROE

-200
Deeply negative

ROA

-177
Deeply negative

Business Description

Conexeu Sciences Inc. is a Reno, Nevada-based company founded in 2022 that creates collagen-based scaffold products designed to support tissue repair and regeneration across medical and aesthetic applications. Their core offerings include a collagen extracellular matrix platform and an investigational collagen gel aimed at helping the body rebuild tissue while reducing unwanted inflammation or scarring. These products are being developed as natural alternatives to traditional fillers and implants for uses such as wound care, facial rejuvenation, and body contouring, with regulatory clearance still pending for several applications.

Key Fundamentals

EPS-0.59
ROE-200
ROIC-675
ROA-177
EBITDA, mln-13.58
EV / EBITDA-5.97
EV / EBIT-5.95

Quote Details

Last 2.54
Change -0.29 (-10.25%)
Open 2.85
Volume 515,240
Turnover 1,308,710
Average Volume 384,557

Financial Ratios

Current Ratio5.31
Price / Book14.05
Price / Tangible Book14.05
Debt / Equity0.01

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -18.06% 4 / 100   
1 Month -23.49% 16 / 100   
2 Months -66.93% 4 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog